Alnylam gets FDA Complete Response Letter for treatment for rare issue than can cause heart failure Oct. 9, 2023 at 7:36 a.m. ET by Ciara Linnane Alnylam Pharmaceuticals started at outperform with $208 stock price target at Oppenheimer Sep. 29, 2023 at 7:44 a.m. ET by Tomi Kilgor...
PROAs Alnylam Pharma Shoots Higher, Trade With a Dose of Reality Company's drug trial for heart disease pumps up stock price. ALNY Trade Ideas Feb 4, 2024 9:10 AM EST PRODrawing Up a Play for a Potential Biotech Game Changer The options against the equity of this promising gene-editing...
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success More Articles Select Price, Percent change, or Dollar change as the y-axis. Price Select Area, Line, OHLC or Candlestick as the chart type. Area Volume: Previous Close-
A high-level overview of Alnylam Pharmaceuticals, Inc. (ALNY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Alnylam price target lowered to $300 from $310 at ScotiabankFebruary 14, 2025TipRanks Morgan Stanley Reaffirms Their Hold Rating on Alnylam Pharma (ALNY)February 14, 2025TipRanks Scotiabank Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)February 14, 2025TipRanks Alnylam Pharma (ALNY) Gets ...
Schlüsseldaten Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently ...
Alnylam Pharmaceuticals (USD) 155.90 -0.14 (-0.09%) FeedbackPeersPriceDayYearDate 4502 Takeda 4,166.00 12.00 0.29% -5.92% Apr/09 ACAD Acadia Pharmaceuticals 18.15 0.35 1.97% 1.97% Apr/09 AGIO Agios Pharmaceuticals 29.71 2.01 7.26% 37.61% Apr/09 ALNY Alnylam Pharmaceuticals 155.90 -0.14 ...
Intellia Therapeutics to Lay Off 27% of Workers in Reorganization Jan. 9, 2025 at 4:29 p.m. ET Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster Jun. 24, 2024 at 9:12 a.m. ETby Eleanor Laise Biotech and PharmaThe Biotech Game Is Changing. Watch for Disruptions,...
Get real-time Alnylam Pharmaceuticals (0HD2) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phill...